470 Federal Register / Vol. 60, No. 2 / Wednesday, January 4, 1995 / Notices

Division of Research Grants; Notice of

Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meeting:

Purpose/Agenda: To review individual grant

applications

Name of SEP: Behavioral and Neurosciences

Date: January 11, 1995

Time: 1:00 p.m.

Place: NIH, Westwood Building, Room 232,

Bethesda, MD 20892, Telephone

Conference

Contact Person: Dr. Kenneth Newrock,

Scientific Review Administrator, 5333

Westbard Ave., Room 232, (301) 594–7123

The meeting will be closed in accordance

with the provisions set forth in sec.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

Applications and/or proposals and the

discussions could reveal confidential trade

secrets or commercial property such as

patentable material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

This notice is being published less than 15

days prior to the meeting due to the urgent

need to meet timing limitations imposed by

the grant review cycle.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: December 23, 1994.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–45 Filed 1–3–95; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meetings of the National Cancer

Advisory Board and Its Subcommittees

Pursuant to Pub. L. 92–463, notice is

hereby given of the meetings of the

National Cancer Advisory Board,

National Cancer Institute, and its

Subcommittees on January 9–11, 1995 at

the National Institutes of Health, 9000

Rockville Pike, Bethesda, Maryland

20892. Except as noted below, the

meetings of the Board and its

Subcommittees will be open to the

public to discuss issues relating to

committee business as indicated in the

notice. Attendance by the public will be

limited to space available.

A portion of the Board meeting will

be closed to the public in accordance

with the provisions set forth in secs.

552b(c)(4) and 552b(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications. These

applications and discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal information

concerning the individuals associated

with the applications or programs, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

The Committee Management Office,

National Cancer Institute, National

Institutes of Health, Executive Plaza

North, Room 630, 9000 Rockville Pike,

Bethesda, Maryland 20892 (301/496–

5708), will provide summaries of the

meetings and rosters of the Board

members, upon request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Ms. Carole Frank, Committee

Management Specialist, at 301/496–

5708 in advance of the meeting.

Name of Committee: Subcommittee for

Special Priorities

Contact Person: Ms. Iris Schneider, Building

31, Room 11A48, Bethesda, MD 20892;

(301) 496–5534

Date of Meeting: January 9, 1995

Place of Meeting: Embassy Conference Room,

Hyatt Regency Bethesda, One Bethesda

Metro Center, Bethesda, MD

Open: 7:30 pm to 9:30 pm

Agenda: To discuss issues related to special

priorities.

Name of Committee: National Cancer

Advisory Board

Contact Person: Dr. Marvin R. Kalt, Executive

Plaza North, Room 600A, Bethesda, MD

20892; (301) 496–5147

Dates of Meeting: January 10–11, 1995

Place of Meeting: Building 31C, Conference

Room 10

Open: January 10—8 am to approximately 12

noon

Agenda: Report on activities of the

President’s Cancer Panel; the Director’s

Report on the National Cancer Institute;

and Scientific Presentations

Closed: January 10—3 pm to recess

Agenda: For review and discussion of

individual grant applications

Open: January 11—8 am to adjournment

Agenda: Policy and Scientific Presentations,

Subcommittee Reports; and New

Business.

Name of Committee: Subcommittee on

Planning and Budget

Contact Person: Ms. Cherie Nichols, Building

31, Room 11A19, Bethesda, MD 20892;

(301) 496–5515

Date of Meeting: January 10, 1995

Place of Meeting: Building 31C, Conference

Room 8

Open: 12 pm to 2 pm

Agenda: To discuss the NCI budget and

various planning issues.

Name of Committee: Subcommittee on

Information and Cancer Control

Contact Person: Mr. Paul Van Nevel,

Building 31, Room 10A31, Bethesda, MD

10892; (301) 496–6631

Date of Meeting: January 10, 1995

Place of Meeting: Building 31C, Conference

Room 9

Open: 1 pm to 3 pm

Agenda: To discuss cancer control issues.

Name of Committee: Subcommittee on

Clinical Investigations

Contact Person: Dr. Bruce Chabner, Building

31, Room 3A52, Bethesda, MD 20892;

(301) 496–4291

Date of Meeting: January 10, 1995

Place of Meeting: Building 31C, Conference

Room 8

Open: 2 pm to 3 pm

Agenda: To discuss clinical investigational

issues.

Name of Committee: Subcommittee on

Cancer Centers

Contact Person: Dr. Brian Kimes, Executive

Plaza North, Room 300, Bethesda, MD

20892; (301) 496–8537

Date of Meeting: January 10, 1995

Place of Meeting: Building 31C, Conference

Room 9

Open: Immediately following the recess of

the NCAB’s closed session

Agenda: To discuss the cancer centers.

This notice is being published less

than fifteen days prior to the meeting

due to the urgent need to meet timing

limitations imposed by the grant review

cycle.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control.)

Dated: December 27, 1994.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 95–42 Filed 1–3–95; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meetings

Pursuant to Pub. L. 92–463, notice is

hereby given of the meetings of the

National Cancer Institute for January

and February 1995.

These meetings will be open to the

public to discuss administrative details

or other issues relating to committee

activities as indicated in the notice and

for the review of concepts being

considered for funding. Attendance by

the public will be limited to space

available.

These meetings will be closed to the

public as indicated below in accordance

with the provisions set forth in secs.

552(c)(4) and 552(c)(6), Title 5, U.S.C.

and sec. 10(d) of Pub. L. 92–463, for the

review, discussion and evaluation of

individual grant applications and